4//SEC Filing
Pacira Pharmaceuticals, Inc. 4
Accession 0001181431-13-050917
$PCRXCIK 0001396814operating
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:11 PM ET
Size
8.5 KB
Accession
0001181431-13-050917
Insider Transaction Report
Form 4
Markvicka Taunia
Vice President, Commercial
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2013-09-25−10,000→ 8,349 totalExercise: $5.49Exp: 2020-12-28→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-09-25$5.49/sh+10,000$54,900→ 10,000 total - Sale
Common Stock
2013-09-25$47.00/sh−10,000$470,000→ 0 total
Footnotes (2)
- [F1]The exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock option vests as follows: 25% of the options vested on December 29, 2011; the remaining options vest in successive equal monthly installments over the subsequent 36 months.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001396814
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 6:11 PM ET
- Size
- 8.5 KB